SP667SAFETY & EFFICACY OF COMBINATION THERAPY WITH OMBITASVIR, PARITAPREVIR & RITONAVIR PLUS DASABUVIR IN HCV-INFECTED PATIENTS WITH CHRONIC KIDNEY DISEASE RECEIVING HEMODIALYSIS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.